Hansjürgen Agostini

ORCID: 0000-0002-0331-1109
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Retinal and Optic Conditions
  • Glaucoma and retinal disorders
  • Polyomavirus and related diseases
  • Retinal and Macular Surgery
  • Retinal Development and Disorders
  • Full-Duplex Wireless Communications
  • Ocular Diseases and Behçet’s Syndrome
  • Angiogenesis and VEGF in Cancer
  • Retinopathy of Prematurity Studies
  • Intraocular Surgery and Lenses
  • Plant Virus Research Studies
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Antenna Design and Analysis
  • Traumatic Ocular and Foreign Body Injuries
  • interferon and immune responses
  • Immune cells in cancer
  • Facial Trauma and Fracture Management
  • Cancer, Hypoxia, and Metabolism
  • Vascular Malformations Diagnosis and Treatment
  • Viral-associated cancers and disorders
  • Corneal surgery and disorders
  • Protease and Inhibitor Mechanisms
  • Axon Guidance and Neuronal Signaling

University of Freiburg
2016-2025

University Medical Center Freiburg
2016-2025

Ophthalmology Clinic
2016-2025

Augenklinik Universitätsklinikum Würzburg
2019-2024

Eye Center
2017-2024

University of Sheffield
2024

University of Bonn
2024

Bicêtre Hospital
2015-2019

University Hospital of Basel
2017

Universität Hamburg
2017

Jeffrey S. Heier Arshad M. Khanani Carlos Quezada-Ruiz Karen Basu Philip J. Ferrone and 95 more Christopher Brittain Marta S. Figueroa Hugh Lin Frank G. Holz Vaibhavi Patel Timothy Y. Y. Lai David G. Silverman Carl D. Regillo Balakumar Swaminathan Francesco Viola Chui Ming Gemmy Cheung Tien Yin Wong Ashkan M. Abbey Elmira Abdulaeva Prema Abraham Alfredo Adán Hansjürgen Agostini Arturo Alezzandrini Virgil Alfaro Arghavan Almony Lebriz Altay Payam Amini Andrew N. Antoszyk Etelka Aradi Luís Arias Jennifer Arnold Riaz Asaria Sergei Astakhov Yury S. Astakhov Carl C. Awh Chandra Balaratnasingam Sanjiv Banerjee Caroline R. Baumal Matthias Becker Rubens Belfort Galina Bratko William Jr. Z Bridges Jamin S. Brown David M. Brown M V Budzinskaya S. Buffet Stuart C Burgess Ik Soo Byon Carlo Cagini Jorge I. Calzada Stone Cameron Peter A. Campochiaro John S. Carlson Ângela Carneiro Clement K. Chan Emmanuel Chang Andrew Chang Daniel L. Chao Nauman Chaudhry Caroline Chee Andrew Cheek Shih‐Jen Chen San‐Ni Chen Chui Ming Gemmy Cheung Saradha Chexal Mark Chittum David R. Chow Abosede Cole B. Connolly Pierre Loïc Cornut Stephen Couvillion Carl J. Danzig Vesselin Daskalov Amr Dessouki François Devin Michael Dollin Rosa Dolz Louise Downey Richard F. Dreyer Pravin U. Dugel David Eichenbaum Bora Eldem Robert E. Engstrom Joan Josep Escobar Nicole Eter David Faber Naomi S. Falk Leonard Feiner Alvaro Fernandez Vega Philip J. Ferrone Marta S. Figueroa Howard F. Fine Mitchell S. Fineman Gregory M. Fox Catherine Français Pablo Moreno Franco Samantha Fraser‐Bell Nicholas Fung Federico Furno Sola Richard Gale

10.1016/s0140-6736(22)00010-1 article EN The Lancet 2022-01-24
Charles C. Wykoff Francis Abreu Anthony P. Adamis Karen Basu David Eichenbaum and 95 more Zdenka Hašková Hugh Lin Anat Loewenstein Shaun Mohan Ian Pearce Taiji Sakamoto Patricio G. Schlottmann David G. Silverman Jennifer K. Sun John A. Wells Jeffrey R. Willis Ramin Tadayoni Thomas M. Aaberg Ashkan M. Abbey Elmira Abdulaeva Santiago Abengoechea Prema Abraham Thomas Ach Serrhel G. Adams Alfredo Adán Sean D. Adrean Hansjürgen Agostini Suhail Alam Arturo Alezzandrini Virgil Alfaro Daniel Aliseda Arghavan Almony Pedro Amat Payam Amini Andrew N. Antoszyk Luís Arias Riaz Asaria Marcos Pereira de Ávila Carl C. Awh Joaquín Bafalluy Carl W. Baker Francesco Bandello Mark Barakat Karen Barraza György Bátor Caroline R. Baumal Rubens Belfort Chris Bergstrom George Bertolucci Thomas W. Bochow Matthias Bolz Emilia Borcz Arnaldo Furman Bordon David S. Boyer Galina Bratko Michael H. Brent Jamin S. Brown David M. Brown M V Budzinskaya S. Buffet Stuart C Burgess Ben Burton Miguel Busquets Francisco Cabrera Carlo Cagini Jorge I. Calzada Peter A. Campochiaro John S. Carlson Alessandro Castellarin Carlos Eduardo Cava Voraporn Chaikitmongkol Clement Chan Emmanuel Chang Jonathan S. Chang Andrew Chang Steve Charles Nauman Chaudhry Caroline Chee Judy Chen Fred K. Chen Shih‐Jen Chen Richard Cheong-Leen Allen Chiang Mark Chittum David R. Chow B. Connolly Pierre Loïc Cornut Karl G. Csaky Carl J. Danzig Arup Das Vesselin Daskalov Carmen Desco Amr Dessouki John D. Dickinson Brian Do Michael Dollin Pravin U. Dugel Jaroslava Dusova David Eichenbaum Bora Eldem

10.1016/s0140-6736(22)00018-6 article EN The Lancet 2022-01-24
Arshad M. Khanani Aachal Kotecha Andrew Chang Shih‐Jen Chen Youxin Chen and 95 more Robyn H. Guymer Jeffrey S. Heier Frank G. Holz Tomohiro Iida Jane A. Ives Jennifer I. Lim Hugh Lin Stephan Michels Carlos Quezada-Ruiz Ursula Schmidt‐Erfurth David G. Silverman Rishi P. Singh Balakumar Swaminathan Jeffrey R. Willis Ramin Tadayoni Ashkan M. Abbey Elmira Abdulaeva Prema Abraham Alfredo Adán Hansjürgen Agostini Arturo Alezzandrini Virgil Alfaro Arghavan Almony Lebriz Altay Payam Amini Andrew N. Antoszyk Etelka Aradi Luís Arias Jennifer Arnold Riaz Asaria Sergei Astakhov Yury S. Astakhov Carl C. Awh Chandra Balaratnasingam Sanjiv Banerjee Caroline R. Baumal Matthias Becker Rubens Belfort Galina Bratko William Bridges Jamin S. Brown David M. Brown M V Budzinskaya S. Buffet Stuart C Burgess Ik Soo Byon Carlo Cagini Jorge I. Calzada Stone Cameron Peter A. Campochiaro John S. Carlson Ângela Carneiro Clement Chan Emmanuel Chang Andrew Chang Daniel L. Chao Nauman Chaudhry Caroline Chee Andrew Cheek Shih‐Jen Chen San‐Ni Chen Chui Ming Gemmy Cheung Saradha Chexal Mark Chittum David R. Chow Abosede Cole B. Connolly Pierre Loïc Cornut Stephen Couvillion Carl J. Danzig Vesselin Daskalov Amr Dessouki François Devin Michael Dollin Rosa Dolz Louise Downey Richard F. Dreyer Pravin U. Dugel David Eichenbaum Bora Eldem Robert E. Engstrom Joan Josep Escobar Nicole Eter David Faber Naomi S. Falk Leonard Feiner Alvaro Fernandez Vega Philip J. Ferrone Marta S. Figueroa Howard F. Fine Mitchell S. Fineman Gregory M. Fox Catherine Français Pablo Moreno Franco Samantha Fraser‐Bell

PurposeTo evaluate 2-year efficacy, durability, and safety of the bispecific antibody faricimab, which inhibits both angiopoietin-2 VEGF-A.DesignTENAYA (ClinicalTrials.gov identifier, NCT03823287) LUCERNE NCT03823300) were identically designed, randomized, double-masked, active comparator-controlled phase 3 noninferiority trials.ParticipantsTreatment-naive patients with neovascular age-related macular degeneration (nAMD) 50 years age or older.MethodsPatients randomized (1:1) to intravitreal...

10.1016/j.ophtha.2024.02.014 article EN cc-by Ophthalmology 2024-02-19

The human polyomavirus JC (JCV) causes the central demyelinating disease progressive multifocal leukoencephalopathy in about 5% of AIDS patients. To characterize type profile JCV a control population United States, 54 females (10 to 79 years age; average age, 43.4 years) and 51 males (18 94 47.9 were examined for excretion different genotypes their urine by PCR followed direct cycle sequencing. group consisted 89 patients general medical clinic addition 16 healthy volunteers. overall...

10.1128/jcm.34.1.159-164.1996 article EN Journal of Clinical Microbiology 1996-01-01

The human polyomavirus JC (JCV) causes the central nervous system demyelinating disease progressive multifocal leukoencephalopathy. Previously, we showed that 40% of Caucasians in United States excrete JCV urine as detected by PCR. We have now studied 68 Navaho from New Mexico, 25 Flathead Montana, and 29 Chamorro Guam. By using PCR amplification a fragment VP1 gene, DNA was 45 (66%) Navaho, 14 (56%) Flathead, 20 (69%) Chamorro. Genotyping viral DNAs these cohorts cycle sequencing...

10.1073/pnas.94.26.14542 article EN Proceedings of the National Academy of Sciences 1997-12-23

<h3>Background</h3> Anti vascular endothelial growth factor (VEGF) therapy is an established treatment for various retinal diseases. Long-term data on injection frequencies and visual acuity (VA), however, are still rare. <h3>Methods</h3> Five-year analysis of real-life VA developments patterns from 2072 patients (2577 eyes; 33 187 injections) with chronically active disease undergoing pro-re-nata age-related macular degeneration (AMD), diabetic oedema (DME), vein occlusion (RVO) myopic...

10.1136/bjophthalmol-2016-308668 article EN cc-by-nc British Journal of Ophthalmology 2016-05-23

Age-related macular degeneration (AMD) is the most common reason of visual impairment in elderly Western countries. The retinal pigment epithelial cells (RPE) causes secondarily adverse effects on neural retina leading to loss. aging characteristics RPE involve lysosomal accumulation lipofuscin and extracellular protein aggregates called "drusen". Molecular mechanisms behind aggregations are weakly understood. There intriguing evidence suggesting that SQSTM1/p62, together with autophagy, has...

10.1371/journal.pone.0069563 article EN cc-by PLoS ONE 2013-07-29

SARS-CoV-2 is assumed to use angiotensin-converting enzyme 2 (ACE2) and other auxiliary proteins for cell entry. Recent studies have described conjunctival congestion in 0.8% of patients with laboratory-confirmed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), there has been speculation that can be transmitted through the conjunctiva. However, it currently unclear whether epithelial cells express ACE2 its cofactors. In this study, a total 38 samples from patients, including 12...

10.1002/jmv.25981 article EN cc-by Journal of Medical Virology 2020-05-06

Real-life clinical outcomes of patients treated with anti-VEGF drugs for neovascular age-related macular degeneration (nAMD), diabetic edema (DME), or secondary to branch retinal vein occlusion (BRVO) are often inferior results from randomized trials. This observational cohort study investigates treatment adherence and real-life within the first year treatment.A total 708 treatment-naïve (466 nAMD, 134 DME, 108 BRVO) were included. Patients followed a PRN protocol three intravitreal...

10.2147/opth.s151611 article EN cc-by-nc Clinical ophthalmology 2017-12-01

PurposeTo compare the efficacy and safety of abicipar every 8 weeks quarterly (after initial doses) versus ranibizumab 4 in treatment-naïve patients with neovascular age-related macular degeneration (AMD).DesignTwo randomized, multicenter, double-masked, parallel-group, active-controlled, phase 3 clinical trials (CEDAR, SEQUOIA) identical protocols were conducted. Data from both pooled for analysis.ParticipantsPatients active choroidal neovascularization secondary to AMD best-corrected...

10.1016/j.ophtha.2020.03.035 article EN cc-by-nc-nd Ophthalmology 2020-04-09

The applications of deep sequencing technologies in life science research and clinical diagnostics have increased rapidly over the last decade. Although fast algorithms for data processing exist, intuitive, portable solutions analysis are still rare. For this purpose, we developed a web-based transcriptome database, which provides platform-independent, intuitive solution to easily explore compare ocular gene expression 100 diseased healthy human tissue samples from 15 different types...

10.1016/j.ygeno.2022.110286 article EN cc-by Genomics 2022-02-03
Tien Yin Wong Zdenka Hašková Kemal Asik Caroline R. Baumal Karl G. Csaky and 95 more Nicole Eter Jane A. Ives Glenn J. Jaffe Jean‐François Korobelnik Hugh Lin Toshinori Murata Paisan Ruamviboonsuk Patricio G. Schlottmann András Seres David G. Silverman Xiaodong Sun Yannan Tang John A. Wells Young Hee Yoon Charles C. Wykoff Thomas M. Aaberg Ashkan M. Abbey Elmira Abdulaeva Santiago Abengoechea Prema Abraham Thomas Ach Serrhel G. Adams Alfredo Adán Sean D. Adrean Hansjürgen Agostini Suhail Alam Arturo Alezzandrini Virgil Alfaro Daniel Aliseda Arghavan Almony Pedro Amat Payam Amini Andrew N. Antoszyk Luís Arias Riaz Asaria Marcos Pereira de Ávila Carl C. Awh Joaquín Bafalluy Carl W. Baker Francesco Bandello Mark Barakat Karen Barraza György Bátor Caroline R. Baumal Rubens Belfort Chris Bergstrom George Bertolucci Thomas W. Bochow Matthias Bolz Emilia Borcz Arnaldo Furman Bordon David S. Boyer Galina Bratko Michael H. Brent Jamin S. Brown David M. Brown M V Budzinskaya S. Buffet Stuart C Burgess Ben Burton Miguel Busquets Francisco Cabrera Carlo Cagini Jorge I. Calzada Peter A. Campochiaro John S. Carlson Alessandro Castellarin Carlos Eduardo Cava Voraporn Chaikitmongkol Clement Chan Emmanuel Chang Jonathan S. Chang Andrew Chang Steve Charles Nauman Chaudhry Caroline Chee Judy Chen Fred K. Chen Shih‐Jen Chen Richard Cheong-Leen Allen Chiang Mark Chittum David R. Chow B. Connolly Pierre Loïc Cornut Karl G. Csaky Carl J. Danzig Arup Das Vesselin Daskalov Carmen Desco Amr Dessouki John D. Dickinson Brian Do Michael Dollin Pravin U. Dugel

10.1016/j.ophtha.2023.12.026 article EN cc-by-nc-nd Ophthalmology 2023-12-28

Meta-analyses of case series non-arteritic central retinal artery occlusion (CRAO) indicate beneficial effects intravenous thrombolysis when initiated early after symptom onset. Randomized data are lacking to address this question.

10.1177/17474930241248516 article EN International Journal of Stroke 2024-04-09

10.1007/s00417-007-0569-6 article EN Graefe s Archive for Clinical and Experimental Ophthalmology 2007-03-13

Abstract Myeloid cells such as resident retinal microglia (MG) or infiltrating blood‐derived macrophages (Mϕ) accumulate in areas of ischemia and neovascularization (RNV) modulate neovascular eye disease. Their temporospatial distribution biological function this process, however, remain unclarified. Using state‐of‐the‐art methods, including cell‐specific reporter mice high‐throughput RNA sequencing (RNA Seq), study determined the extent MG proliferation Mϕ infiltration with RNV Cx3cr1...

10.1002/glia.23810 article EN cc-by-nc-nd Glia 2020-03-09

Distinctive genotypes of JC virus have been described for the major continental landmasses. Studies on European-Americans and small cohorts in Europe showed predominantly Type 1. Types 2 7 are found Asia, 3 6 Africa. These differ sequence by about 1–3%. Each genotype may several subtypes which from each other 0·5–1%. The can be defined a distinctive pattern nucleotides typing region VP 1 gene. This genotyping approach has confirmed phylogenetic reconstruction using entire genome exclusive...

10.1099/0022-1317-82-5-1221 article EN Journal of General Virology 2001-05-01

Infection of injury results in several systemic and central reactions termed the acute phase response (APR). Substantial evidence suggests that cytokines induced by microbes initiate APR. We compared APR rabbits a model bacterial stimulus, lipopolysaccharide (LPS), to viral polyriboinosinic:polyribocytidylic acid (poly I:C). The cytokine mRNA responses mouse macrophage cell line (RAW 264.7) LPS or poly I:C were also determined. Rabbits injected intravenously intracerebroventricularly with...

10.1152/ajpregu.1994.267.6.r1596 article EN AJP Regulatory Integrative and Comparative Physiology 1994-12-01

A number of key ocular diseases, including diabetic retinopathy and age-related macular degeneration, are characterized by localized areas epithelial or endothelial damage, which can ultimately result in the growth fragile new blood vessels, vitreous hemorrhage, retinal detachment. VEGF-A(165), principal neovascular agent angiogenic conditions, is formed proximal splice site selection its terminal exon 8. Alternative splicing this results an antiangiogenic isoform, VEGF-A(165)b,...

10.1167/iovs.09-4296 article EN Investigative Ophthalmology & Visual Science 2010-03-18

The next-generation ophthalmic anti-VEGF therapeutics must aim at being superior to the currently available agents with regard potency and improved drug delivery, while still stable safe use elevated concentrations. We show here generation of a set highly potent VEGF-A antagonistic DARPins (designed ankyrin repeat proteins) delivering these properties. single-digit picomolar affinity human were generated using ribosome display selections. Specific binding was confirmed by ELISA endothelial...

10.1007/s10456-012-9302-0 article EN cc-by Angiogenesis 2012-09-15

Retinal neovascularization has been intensively investigated in the mouse model of oxygen-induced retinopathy (OIR). Here, we studied contribution microglial cells to vascular regression during hyperoxic phase and retinal hypoxic phase.Mice expressing green fluorescent protein (GFP) under Cx3cr1 promoter labeling were kept 75% oxygen from postnatal day 7 (P7) P12. Microglial cell density was quantified at different time points positions flat mounts. activation determined by switch ramified...

10.1186/1742-2094-8-120 article EN cc-by Journal of Neuroinflammation 2011-09-23
Coming Soon ...